Related references
Note: Only part of the references are listed.Intravitreal bevacizumab for surgical treatment of severe proliferative diabetic retinopathy
Raffaello di Lauro et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2010)
Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema
Michael J. Elman et al.
OPHTHALMOLOGY (2010)
A Prospective Randomized Trial of Intravitreal Bevacizumab or Laser Therapy in the Management of Diabetic Macular Edema (BOLT Study) 12-Month Data: Report 2
Michel Michaelides et al.
OPHTHALMOLOGY (2010)
THE RESULTS OF INTRAVITREAL BEVACIZUMAB INJECTIONS FOR PERSISTENT NEOVASCULARIZATIONS IN PROLIFERATIVE DIABETIC RETINOPATHY AFTER PHOTOCOAGULATION THERAPY
Hidayet Erdol et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2010)
Intravitreal pegaptanib sodium (Macugen®) for diabetic macular oedema
Giuseppe Querques et al.
ACTA OPHTHALMOLOGICA (2009)
Intraoperative bleeding during vitrectomy for diabetic tractional retinal detachment with versus without preoperative intravitreal bevacizumab (IBeTra study)
D. da R. Lucena et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2009)
Can a preoperative bevacizumab injection prevent recurrent postvitrectomy diabetic vitreous haemorrhage?
M. R. Romano et al.
EYE (2009)
Comparison of two doses of primary intravitreal bevacizumab (Avastin) for diffuse diabetic macular edema: results from the Pan-American Collaborative Retina Study Group (PACORES) at 12-month follow-up
J. Fernando Arevalo et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2009)
Acute Visual Acuity Loss Following Intravitreal Bevacizumab for Diabetic Macular Edema
Eric Chen et al.
OPHTHALMIC SURGERY LASERS & IMAGING (2009)
Primary Intravitreal Bevacizumab for Diffuse Diabetic Macular Edema The Pan-American Collaborative Retina Study Group at 24 Months
J. Fernando Arevalo et al.
OPHTHALMOLOGY (2009)
Randomized Trial of Intravitreal Bevacizumab Alone or Combined with Triamcinolone versus Macular Photocoagulation in Diabetic Macular Edema
Masoud Soheilian et al.
OPHTHALMOLOGY (2009)
Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
Quan Dong Nguyen et al.
OPHTHALMOLOGY (2009)
Intravitreal Bevacizumab for Prevention of Early Postvitrectomy Hemorrhage in Diabetic Patients A Randomized Clinical Trial
Hamid Ahmadieh et al.
OPHTHALMOLOGY (2009)
Microincision Vitrectomy Surgery and Intravitreal Bevacizumab as a Surgical Adjunct to Treat Diabetic Traction Retinal Detachment
Yusuke Oshima et al.
OPHTHALMOLOGY (2009)
EFFICACY OF 1.25 MG VERSUS 2.5 MG INTRAVITREAL BEVACIZUMAB FOR DIABETIC MACULAR EDEMA Six-Month Results of a Randomized Controlled Trial
Dennis S. C. Lam et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2009)
INTRAVITREAL BEVACIZUMAB AND PANRETINAL PHOTOCOAGULATION FOR PROLIFERATIVE DIABETIC RETINOPATHY ASSOCIATED WITH VITREOUS HEMORRHAGE
Yu-Hsun Huang et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2009)
PANRETINAL PHOTOCOAGULATION COMBINED WITH INTRAVITREAL BEVACIZUMAB IN HIGH-RISK PROLIFERATIVE DIABETIC RETINOPATHY
Won Bin Cho et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2009)
BEVACIZUMAB PRETREATMENT IN VITRECTOMY WITH SILICONE OIL FOR SEVERE DIABETIC RETINOPATHY
Po-Ting Yeh et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2009)
Intravitreal bevacizumab (avastin) for proliferative diabetic retinopathy: 6-months follow-up
J. F. Arevalo et al.
EYE (2009)
Panretinal photocoagulation versus PRP plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy (IBeHi study)
Matheus Tonello et al.
ACTA OPHTHALMOLOGICA (2008)
Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema
Masahiko Shimura et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2008)
Injection of intravitreal bevacizumab (Avastin) as a preoperative adjunct before vitrectomy surgery in the treatment of severe proliferative diabetic retinopathy (PDR)
Stanislao Rizzo et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2008)
Intravitreal bevacizumab in active progressive proliferative diabetic retinopathy
Siamak Moradian et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2008)
A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema
Michael S. Ip et al.
OPHTHALMOLOGY (2008)
Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema
Daniel Kook et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2008)
Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular edema; a placebo-controlled, randomized clinical trial
Hamid Ahmadieh et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2008)
Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy
J. F. Arevalo et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2008)
Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study)
L. Paccola et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2008)
Targeting vascular endothelial growth factor - A promising strategy for treating age-related macular degeneration
Michael Waisbourd et al.
DRUGS & AGING (2007)
Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE Study)
Rodrigo Jorge et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2006)
Ranibizumab for neovascular age-related macular degeneration
Philip J. Rosenfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Ranibizumab versus verteporfin for neovascular age-related macular degeneration
David M. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy
Robert L. Avery et al.
OPHTHALMOLOGY (2006)
A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema
Dal W. Chun et al.
OPHTHALMOLOGY (2006)
Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals
AP Adamis et al.
OPHTHALMOLOGY (2006)
A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema
ET Cunningham et al.
OPHTHALMOLOGY (2005)
Share Paper
